Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Preclinical assessment of combined BCL-2 and MCL-1 inhibi... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Preclinical assessment of combined BCL-2 and MCL-1 inhibition in high-risk neuroblastoma.
0
Authors
Lindy Vernooij
12 more
Lindy Vernooij
•
Alvin Kamili
10 more
•
M. Dolman
Published
June 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
EJC Paediatric Oncology
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Neurology
Show all topics
DOI
10.1016/j.ejcped.2024.100168
License
CC-BY-NC-ND
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
EJC Paediatric Oncology
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Neurology
Show all topics
DOI
10.1016/j.ejcped.2024.100168
License
CC-BY-NC-ND
